A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma

Abstract Background Lung adenocarcinoma (LUAD) is characterized by high morbidity and mortality rates and poor prognosis. N7-methylguanosine play an increasingly vital role in lung adenocarcinoma. However, the prognostic value of N7-methylguanosine related-miRNAs in lung adenocarcinoma remains uncle...

Full description

Bibliographic Details
Main Authors: Han-ping Duan, Jian-hui Yan, Lin Nie, Ye Wang, Hui Xie
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-022-02290-7
_version_ 1797952728463310848
author Han-ping Duan
Jian-hui Yan
Lin Nie
Ye Wang
Hui Xie
author_facet Han-ping Duan
Jian-hui Yan
Lin Nie
Ye Wang
Hui Xie
author_sort Han-ping Duan
collection DOAJ
description Abstract Background Lung adenocarcinoma (LUAD) is characterized by high morbidity and mortality rates and poor prognosis. N7-methylguanosine play an increasingly vital role in lung adenocarcinoma. However, the prognostic value of N7-methylguanosine related-miRNAs in lung adenocarcinoma remains unclear. Methods In the study, the mRNA and miRNA expression profiles and corresponding clinical informations were downloaded from the public database. The prognostic signature was built using least absolute shrinkage and selection operator Cox analysis. The Kaplan–Meier method was used to compare survival outcomes between the high- and low-risk groups. Signatures for the development of lung adenocarcinoma were tested using univariate and multivariate Cox regression models. Single-sample gene set enrichment analysis was used to determine the immune cell infiltration score. First, we predicted METTL1 and WDR4 chemosensitivities based on a public pharmacogenomics database. The area under the receiver operating characteristic curve showed that the performance of signature in 1-,3-, and 5-year survival predictions were 0.68, 0.65, and 0.683, respectively. Results We established a novel prognostic signature consisting of 9 N7-Methylguanosine related miRNAs using least absolute shrinkage and selection operator Cox analysis. Patients in the high-risk group had shorter survival times than those in the low-risk group did. The calibration curves at 1, 3, and 5-year also illustrate the high predictive power of the structure. Signature was corrected using the Toumor stage. The expression levels of METTL1 and WDR4 significantly correlated with the sensitivity of cancer cells to antitumor drugs. Conclusions A novel signature constructed using 9 N7-methylguanosine related-miRNAs can be used for prognostic prediction.
first_indexed 2024-04-10T22:50:51Z
format Article
id doaj.art-cbf3fee9f14b471ea836518b90ce812b
institution Directory Open Access Journal
issn 1471-2466
language English
last_indexed 2024-04-10T22:50:51Z
publishDate 2023-01-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj.art-cbf3fee9f14b471ea836518b90ce812b2023-01-15T12:03:36ZengBMCBMC Pulmonary Medicine1471-24662023-01-0123111310.1186/s12890-022-02290-7A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinomaHan-ping Duan0Jian-hui Yan1Lin Nie2Ye Wang3Hui Xie4Department of Nuclear Medicine, Affiliated Hospital (Clinical College) of Xiangnan UniversityDepartment of General Medicine, Affiliated Hospital (Clinical College) of Xiangnan UniversityDepartment of Radiology, Affiliated Hospital (Clinical College) of Xiangnan UniversityDepartment of Thoracic Surgery, Affiliated Hospital (Clinical College) of Xiangnan UniversityDepartment of Radiation Oncology, Affiliated Hospital (Clinical College) of Xiangnan UniversityAbstract Background Lung adenocarcinoma (LUAD) is characterized by high morbidity and mortality rates and poor prognosis. N7-methylguanosine play an increasingly vital role in lung adenocarcinoma. However, the prognostic value of N7-methylguanosine related-miRNAs in lung adenocarcinoma remains unclear. Methods In the study, the mRNA and miRNA expression profiles and corresponding clinical informations were downloaded from the public database. The prognostic signature was built using least absolute shrinkage and selection operator Cox analysis. The Kaplan–Meier method was used to compare survival outcomes between the high- and low-risk groups. Signatures for the development of lung adenocarcinoma were tested using univariate and multivariate Cox regression models. Single-sample gene set enrichment analysis was used to determine the immune cell infiltration score. First, we predicted METTL1 and WDR4 chemosensitivities based on a public pharmacogenomics database. The area under the receiver operating characteristic curve showed that the performance of signature in 1-,3-, and 5-year survival predictions were 0.68, 0.65, and 0.683, respectively. Results We established a novel prognostic signature consisting of 9 N7-Methylguanosine related miRNAs using least absolute shrinkage and selection operator Cox analysis. Patients in the high-risk group had shorter survival times than those in the low-risk group did. The calibration curves at 1, 3, and 5-year also illustrate the high predictive power of the structure. Signature was corrected using the Toumor stage. The expression levels of METTL1 and WDR4 significantly correlated with the sensitivity of cancer cells to antitumor drugs. Conclusions A novel signature constructed using 9 N7-methylguanosine related-miRNAs can be used for prognostic prediction.https://doi.org/10.1186/s12890-022-02290-7Lung adenocarcinomaN7-methylguanosinemiRNA
spellingShingle Han-ping Duan
Jian-hui Yan
Lin Nie
Ye Wang
Hui Xie
A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma
BMC Pulmonary Medicine
Lung adenocarcinoma
N7-methylguanosine
miRNA
title A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma
title_full A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma
title_fullStr A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma
title_full_unstemmed A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma
title_short A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma
title_sort noval prognostic signature of the n7 methylguanosine m7g related mirna in lung adenocarcinoma
topic Lung adenocarcinoma
N7-methylguanosine
miRNA
url https://doi.org/10.1186/s12890-022-02290-7
work_keys_str_mv AT hanpingduan anovalprognosticsignatureofthen7methylguanosinem7grelatedmirnainlungadenocarcinoma
AT jianhuiyan anovalprognosticsignatureofthen7methylguanosinem7grelatedmirnainlungadenocarcinoma
AT linnie anovalprognosticsignatureofthen7methylguanosinem7grelatedmirnainlungadenocarcinoma
AT yewang anovalprognosticsignatureofthen7methylguanosinem7grelatedmirnainlungadenocarcinoma
AT huixie anovalprognosticsignatureofthen7methylguanosinem7grelatedmirnainlungadenocarcinoma
AT hanpingduan novalprognosticsignatureofthen7methylguanosinem7grelatedmirnainlungadenocarcinoma
AT jianhuiyan novalprognosticsignatureofthen7methylguanosinem7grelatedmirnainlungadenocarcinoma
AT linnie novalprognosticsignatureofthen7methylguanosinem7grelatedmirnainlungadenocarcinoma
AT yewang novalprognosticsignatureofthen7methylguanosinem7grelatedmirnainlungadenocarcinoma
AT huixie novalprognosticsignatureofthen7methylguanosinem7grelatedmirnainlungadenocarcinoma